Furthermore, antigen-presenting cells (APCs)-based vaccines, such as dendritic cells, induce T-cell activation and an anti-cancer immune reaction against a carcinoembryonic antigen as well as the telomerase reverse transcriptase [56]. This evidence concerns the gene CEACAM5 and cancer.